retatrutide triple agonist phase 2 nejm 2023 obesity results Retatrutide: A Shaping the Future of Metabolic Care Retatrutide (Eli Lilly's triple GLP-1/GIP/Glucagon

Robbins says

While most devices only report prandial (i.e., bolus) insulin as IOB, people with type 1 diabetes who are using any kind of continuous subcutaneous insulin infusion (CSII) device can see how much insulin the pump calculates is on board. When insulin basal rate reductions are started approximately 90120 min prior to the start of endurance activity (129), especially in the morning before the first meal (130), significant hypoglycemia protection is achieved for individuals on standard CSII medication

Regular monitoring For known iron deficiency, we recommend checking iron levels approximately every six months

Can I use sterile water instead of bacteriostatic water for retatrutide

it increases side effects and waste